Tripeptide-29 is a collagen-derived tripeptide fragment that has been the subject of experimental studies for its ability to modulate collagen type I gene expression, enhance ECM remodeling, and stabilize dermal protein architecture in in-vitro models. It serves as a model compound for research on peptide-mediated tissue repair, structural protein turnover, and cellular communication within connective tissue systems.


